ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wyoming » Pulmonary Disease

Top Pulmonary Disease Prescribers in Wyoming

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID SHRADER M.D.

Pulmonary Disease

1,767

$1.19M

167
147 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

39%
prescriptions for brand name drugs

$675
Average prescription price

SODIENYE TETENTA MB.BS

Pulmonary Disease

825

$298K

104
76 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

68%
prescriptions for brand name drugs

$362
Average prescription price

MUHAMMAD HUSSIENO MD

Pulmonary Disease

1,837

$654K

288
214 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

69%
prescriptions for brand name drugs

$356
Average prescription price

PETER FORT M.D.

Pulmonary Disease

1,036

$131K

141
106 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

46%
prescriptions for brand name drugs

$126
Average prescription price

HARMON DAVIS MD

Pulmonary Disease

9,122

$956K

467
415 are 65+

0%
patients receiving schedule two controlled substances

3%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

30%
prescriptions for brand name drugs

$105
Average prescription price

STEPHEN MAININI MD

Pulmonary Disease

4,787

$305K

398
328 are 65+

6%
patients receiving schedule two controlled substances

7%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

29%
prescriptions for brand name drugs

$64
Average prescription price

STEVEN REEB MD

Pulmonary Disease

8,608

$515K

395
302 are 65+

0%
patients receiving schedule two controlled substances

10%
patients receiving schedule three controlled substances

1%
prescriptions for patients 65+ for potentially dangerous drugs

26%
prescriptions for brand name drugs

$60
Average prescription price

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank